Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.
- Company Anticipates Submitting for U.S. Accelerated Approval in H1 2026 - WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage...
- DYNE-101 in DM1: Dyne plans to initiate global Registrational Expansion Cohort of ACHIEVE trial with registrational dose of 6.8 mg/kg Q8W following study data showing splicing correction and...
WALTHAM, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...
WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.1822 | 8.6166180758 | 13.72 | 14.94 | 13.235 | 4204400 | 13.68506124 | CS |
4 | -10.8678 | -42.1722933644 | 25.77 | 26.18 | 13.235 | 3157325 | 15.22831411 | CS |
12 | -14.3878 | -49.1218846023 | 29.29 | 35.68 | 13.235 | 1674410 | 20.54011772 | CS |
26 | -28.7078 | -65.8284797065 | 43.61 | 47.45 | 13.235 | 1414712 | 27.91522856 | CS |
52 | -6.2078 | -29.4069161535 | 21.11 | 47.45 | 13.235 | 1328423 | 28.68675489 | CS |
156 | 7.8822 | 112.282051282 | 7.02 | 47.45 | 4.3 | 774419 | 21.86698366 | CS |
260 | -8.5478 | -36.4511727079 | 23.45 | 47.45 | 4.3 | 622328 | 21.25980715 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관